Ratings by Jones Trading (Boris Peaker)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 6/15/2026 | Elicio Therapeutics | ELTX | Downgrade | Hold (Buy) |
14.85 (4.14) |
-72.12% | Details | |
| 5/14/2026 | Adlai Nortye Ltd. | ANL | New Coverage | Buy (N/A) |
13.94 (10.40) |
-25.39% | Details | |
| 5/6/2026 | OnKure Therapeutics Inc. | OKUR | Downgrade | Hold (Buy) |
4.52 (4.44) |
-1.77% | Details | |
| 4/28/2026 | Janux Therapeutics | JANX | Maintain | Buy (N/A) |
|
Details | ||
| 4/6/2026 | Whitehawk Therapeutics | WHWK | New Coverage | Buy (N/A) |
3.51 (4.46) |
27.07% | Details | |
| 4/6/2026 | Protara Therapeutics | TARA | New Coverage | Buy (N/A) |
5.11 (4.11) |
-19.57% | Details | |
| 4/6/2026 | Prime Medicine | PRME | New Coverage | Buy (N/A) |
3.32 (3.37) |
1.51% | Details | |
| 4/6/2026 | ORIC Pharmaceuticals | ORIC | New Coverage | Buy (N/A) |
8.89 (8.93) |
0.45% | Details | |
| 4/6/2026 | OnKure Therapeutics Inc. | OKUR | New Coverage | Buy (N/A) |
4.29 (4.52) |
5.36% | Details | |
| 4/6/2026 | Oncolytics Biotech | ONCY | New Coverage | Hold (N/A) |
0.96 (0.92) |
-4.17% | Details | |
| 4/6/2026 | Nuvation Bio Inc | NUVB | New Coverage | Buy (N/A) |
4.41 (5.76) |
30.61% | Details | |
| 4/6/2026 | Monopar Therapeutics | MNPR | New Coverage | Buy (N/A) |
55.13 (68.66) |
24.54% | Details | |
| 4/6/2026 | Janux Therapeutics | JANX | New Coverage | Buy (N/A) |
14.84 (14.34) |
-3.37% | Details | |
| 4/6/2026 | IN8bio Inc. | INAB | New Coverage | Buy (N/A) |
1.44 (1.46) |
1.39% | Details | |
| 4/6/2026 | Enliven Therapeutics | ELVN | New Coverage | Buy (N/A) |
38.83 (45.96) |
18.36% | Details | |
| 4/6/2026 | Elicio Therapeutics | ELTX | New Coverage | Buy (N/A) |
10.65 (14.85) |
39.44% | Details | |
| 4/6/2026 | Editas Medicine | EDIT | New Coverage | Buy (N/A) |
2.67 (2.80) |
4.87% | Details | |
| 4/6/2026 | Day One Biopharmaceuticals | DAWN | New Coverage | Hold (N/A) |
21.45 (21.53) |
0.37% | Details | |
| 4/6/2026 | Curis | CRIS | New Coverage | Buy (N/A) |
0.55 (0.43) |
-21.82% | Details | |
| 4/6/2026 | Cullinan Oncology Inc. | CGEM | New Coverage | Buy (N/A) |
14.43 (17.30) |
19.89% | Details | |
| 4/6/2026 | Context Therapeutics | CNTX | New Coverage | Buy (N/A) |
2.72 (0.63) |
-76.84% | Details | |
| 4/6/2026 | CG Oncology | CGON | New Coverage | Buy (N/A) |
67.48 (66.25) |
-1.82% | Details | |
| 4/6/2026 | CervoMed | CRVO | New Coverage | Buy (N/A) |
4.14 (4.13) |
-0.24% | Details | |
| 4/6/2026 | Bolt Biotherapeutics, Inc. | BOLT | New Coverage | Hold (N/A) |
4.29 (4.01) |
-6.53% | Details | |
| 4/6/2026 | Bicara Therapeutics Inc | BCAX | New Coverage | Buy (N/A) |
21.47 (24.55) |
14.35% | Details | |
| 4/6/2026 | Beam Therapeutics Inc | BEAM | New Coverage | Buy (N/A) |
24.66 (35.53) |
44.08% | Details | |
| 4/6/2026 | aTyr Pharma | ATYR | New Coverage | Hold (N/A) |
0.85 (0.47) |
-44.71% | Details | |
| 4/6/2026 | ArriVent BioPharma | AVBP | New Coverage | Buy (N/A) |
24.89 (32.70) |
31.38% | Details | |
| 4/6/2026 | Adicet Bio Inc. | ACET | New Coverage | Buy (N/A) |
6.99 (8.23) |
17.74% | Details |
